ATENOLOL

Course overview

ATENOLOL IS A SECOND-GENERATION BETA-1-SELECTIVE ADRENERGIC ANTAGONIST INDICATED IN THE TREATMENT OF HYPERTENSION, ANGINA PECTORIS, AND ACUTE MYOCARDIAL INFARCTION. NON-FDA APPROVED INDICATIONS INCLUDE TREATMENT OF ARRHYTHMIAS, MIGRAINE PROPHYLAXIS, PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA, ALCOHOL WITHDRAWAL, THYROTOXICOSIS, AND PROPHYLAXIS AGAINST SECONDARY MYOCARDIAL INFARCTION. THIS ACTIVITY OUTLINES THE INDICATIONS, MECHANISM OF ACTION, SAFE ADMINISTRATION, ADVERSE EFFECTS, CONTRAINDICATIONS, MONITORING, AND TOXICITY OF ATENOLOL.